Reliability of identification of 655 sentinel lymph nodes in 263 consecutive patients with malignant melanoma

Journal of the American College of Surgeons

Volumn 198, Issue 6, 2004, Pages 924-932

  Ariyan, Stephan ^a,b   Ariyan, Charlotte ^a   Farber, Leonard R ^b   Fischer, David S ^b   Flynn, Stuart D ^b   Truini, Carolyn ^a  

^a YALE CANCER CENTER   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

LB; lymphazurin blue dye; sentinel lymph node; SLN; TC; technetium 99m sulfur colloid

Indexed keywords

ISOSULFAN BLUE; TECHNETIUM SULFUR COLLOID TC 99M;

ARTICLE; CANCER RISK; CANCER STAGING; CANCER SURGERY; COLLOID; COMPARATIVE STUDY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FROZEN SECTION; HIGH RISK PATIENT; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTERMETHOD COMPARISON; LABORATORY DIAGNOSIS; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MEDICAL RECORD; MELANOMA; OPERATION DURATION; PRIORITY JOURNAL; RADIODIAGNOSIS; RELIABILITY; SENTINEL LYMPH NODE BIOPSY; SURGICAL TECHNIQUE;

FOLLOW-UP STUDIES; FROZEN SECTIONS; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MELANOMA; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; ROSANILINE DYES; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS; TECHNETIUM TC 99M SULFUR COLLOID; TIME FACTORS;

EID: 2942609104     PISSN: 10727515     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jamcollsurg.2004.01.034     Document Type: Article

References (18)

1. Sherman A., TerPetrosian M. Lymph node concentration of radioactive colloidal gold following interstitial injection. Cancer. 6:1953;1238-1240
2. Ariyan S., Kirkwood J.M., Mitchell M.S., et al. Intralymphatic regional surgical adjuvant immunotherapy in high-risk melanoma of the extremities. Surgery. 92:1982;459-463
3. Wanebo H.J., Harpole D., Teats D. Radionucleide lymphoscintigraphy with technetium 99 m antimony sulfide colloid to identify lymphatic drainage of cutaneous melanoma at ambiguous sites in the head, neck and trunk. Cancer. 55:1985;1403-1413
4. Morton D.L., Wen D.R., Wong J.H., et al. Technical details of intraoperative lymphatic mapping for early staged melanoma. Arch Surg. 127:1992;392-399
5. Reintgen D., Cruse C.W., Wells K., et al. The orderly progression of melanoma nodal metastases. Ann Surg. 220:1994;759-767
6. Albertini J.J., Cruse C.W., Rappaport D., et al. Intraoperative radiolymphoscintography. Improved sentinel lymph identification for patients with melanoma. Ann Surg. 223:1996;217-224
7. Cascinelli N., Belli F., Santinami M., et al. Sentinel lymph node biopsy in cutaneous melanoma. WHO melanoma program experience. Ann Surg Oncol. 7:2000;469-474
8. Ariyan S., Mitchell M.S., Kirkwood J.M. Regional isolated perfusion of high risk melanoma of the extremities with imidazole carboxamide. Surg Gynecol Obstet. 158:1984;238-242
9. Corsetti R.L., Allen H., Wanebo H.J. Thin < 1 mm level III and IV melanomas are higher risk lesions for regional failure and warrant sentinel lymph node biopsy. Ann Surg Oncol. 7:2000;456-460
10. Bedrosian I., Faries M.B., DuPont G., et al. Incidence of nodal metastasis in patients with thin primary melanoma (< 1 mm) with vertical growth phase. Ann Surg Oncol. 7:2000;262-267
11. Fusi S., Ariyan S., Sternlicht A. Data on first recurrence after treatment for malignant melanoma in a large patient population. Plast Reconstr Surg. 91:1993;94-98
12. Morton D.L., Thompson J.F., Essner R., et al. Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma. A multicenter trial. Ann Surg. 230:1999;453-463
13. McMasters K.M., Reintgen D.S., Ross M.I., et al. Sentinel lymph node biopsy for melanoma How many radioactive nodes should be removed? Ann Surg Oncol. 8:2001;192-197
14. Gershenwald J.E., Thompson W., Mansfield P.F., et al. Multi-institutional melanoma lymphatic mapping experience The prognostic value of sentinel lymph node status in 162 Stage I and II melanoma patients. J Clin Oncol. 17:1999;976-983
15. Tanis P.J., Boom R.P.A., Koops H.S., et al. Frozen section investigation of the sentinel node in malignant melanoma and breast cancer. Ann Surg Oncol. 8:2001;222-226
16. Bostick P., Essner R., Glass E., et al. Comparison of blue dye and probe-assisted intraoperative lymphatic mapping in melanoma to identify sentinel nodes in 100 lymphatic basins. Arch Surg. 134:1999;43-49
17. Leong S.P., Donegan E., Heffernon W., et al. Adverse reactions to isosulfan blue during selective sentinel lymph node dissection in melanoma. Ann Surg Oncol. 7:2000;361-366
18. Cimmino V.M., Brown A.C., Szocik J.F., et al. Allergic reactions to isosulfan blue during sentinel node biopsy. Surgery. 130:2001;439-442